SCHEMBL4016237

SCHEMBL4016237

CC(C)(C[O])Oc1ccc(Br)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
PPARA Q07869 4/20 0.38
PPARD Q03181 2/20 0.38
MAPT P10636 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
RAB9A P51151 2/20 0.37
LMNA P02545 1/20 0.37
MAPK1 P28482 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
APP P05067 1/20 0.36
MAOB P27338 1/20 0.35
LDHA P00338 1/20 0.34
PPARG P37231 2/20 0.34
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15718370 0.83 ALDH1A1 (0.41) ALDH1A1KDM4EPPARAPPARDMAPT
SCHEMBL17476827 0.81 ALDH1A1 (0.42) ALDH1A1KDM4EPPARAPPARDMAPT
SCHEMBL3723070 0.81 ALDH1A1 (0.42) ALDH1A1KDM4EPPARAPPARDMAPT
SCHEMBL1892567 0.79 ALDH1A1 (0.41) ALDH1A1KDM4EPPARAPPARDMAPT
SCHEMBL2441978 0.79 PPARA (0.53) ALDH1A1PPARAPPARDMAPTMEN1
SCHEMBL3937220 0.78 PPARG (0.39) ALDH1A1PPARAMAPTMEN1KMT2A
SCHEMBL6358939 0.78 KDM4E (0.40) ALDH1A1KDM4EPPARAPPARDMAPT
SCHEMBL21991270 0.77 PPARA (0.43) ALDH1A1KDM4EPPARAPPARDMAPT
SCHEMBL17157400 0.76 MCHR1 (0.41) ALDH1A1KDM4EPPARAPPARDMAPT
SCHEMBL1006518 0.75 ALDH1A1 (0.42) ALDH1A1KDM4EPPARAPPARDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009133970-A1 CRYSTALLINE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-05 WO disclosed
EP-2074117-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-07-01 EP disclosed
WO-2008062905-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-29 WO disclosed